Ginkgo Bioworks Holdings Inc (DNA)
7.285
-1.32
(-15.29%)
USD |
NYSE |
Nov 14, 16:00
7.37
+0.08
(+1.17%)
After-Hours: 20:00
Ginkgo Bioworks Holdings Total Liabilities (Quarterly): 792.18M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 792.18M |
| March 31, 2024 | 594.49M |
| December 31, 2023 | 568.19M |
| September 30, 2023 | 773.71M |
| June 30, 2023 | 788.41M |
| March 31, 2023 | 809.62M |
| December 31, 2022 | 803.04M |
| Date | Value |
|---|---|
| September 30, 2022 | 430.96M |
| June 30, 2022 | 427.16M |
| March 31, 2022 | 443.68M |
| December 31, 2021 | 503.61M |
| September 30, 2021 | 532.62M |
| December 31, 2020 | 205.10M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
205.10M
Minimum
Dec 2020
809.62M
Maximum
Mar 2023
590.21M
Average
568.19M
Median
Dec 2023
Total Liabilities (Quarterly) Benchmarks
| Boston Scientific Corp | 17.12B |
| UnitedHealth Group Inc | 194.85B |
| CEL-SCI Corp | 15.60M |
| AIM ImmunoTech Inc | 9.613M |
| IGC Pharma Inc | 2.714M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.625B |
| Shareholders Equity (Quarterly) | 833.07M |
| Current Ratio | 4.715 |